Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life
Semaglutide is a safe treatment that led to long-term sustained improvements in eating behavior, weight control, and improved metabolic health. Patients reported an improved quality of life, which persisted after body weight stabilization.
Authors
- Hermann L. Müller (ORCID: https://orcid.org/0000-0003-4929-9966)
- Kåre Schmidt Ettrup
- Peter Vestergaard (ORCID: https://orcid.org/0000-0002-9046-2967)
- Dorte Melgaard (ORCID: https://orcid.org/0000-0002-5656-402X)
- Eigil Husted Nielsen (ORCID: https://orcid.org/0000-0002-7990-3557)
- Erlend Gjersdal (ORCID: https://orcid.org/0009-0009-1391-8009)
- Kirsten Vistisen
- Frederik Østergaard Klit (ORCID: https://orcid.org/0009-0009-5627-598X)
- Jakob Dal
Institutions
- Steno Diabetes Centers (DK)
- Aalborg University Hospital (DK)
- Klinikum Oldenburg (DE)
- Aalborg University (DK)
Publication Details
- Journal
- Pituitary
- Published
- 2025-08-19
- DOI
- https://doi.org/10.1007/s11102-025-01564-7
- Citations
- 3
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- Aalborg Universitet
- Aalborg Universitetshospital